{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:02:05Z","timestamp":1791475325726,"version":"4.3.4"},"reference-count":137,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.mayocp.2021.01.009","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T22:05:42Z","timestamp":1611266742000},"page":"989-1005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4327-0927","authenticated-orcid":false,"given":"Mark A.","family":"Cappel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Cappel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.mayocp.2013.09.020","article-title":"Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo Clinic, 2000 to 2011","volume":"89","author":"Cappel","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.009_bib4","first-page":"395","article-title":"Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria","volume":"54","author":"Su","year":"1994","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.009_bib5","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/thx.31.6.660","article-title":"Sarcoidosis of the upper respiratory tract and its association with lupus pernio","volume":"31","author":"Neville","year":"1976","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaad.2020.04.161","article-title":"SNDV (French National Union of Dermatologists-Venereologists). Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France","volume":"83","author":"de Masson","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib8","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jaad.2020.04.093","article-title":"Characterization of acute acral skin lesions in nonhospitalized patients: a case series of 132 patients during the COVID-19 outbreak","volume":"83","author":"Fernandez-Nieto","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.mayocp.2021.01.009_bib9","article-title":"Coronavirus hijacks the body from head to toe, perplexing doctors","author":"McKay","year":"2020","journal-title":"The Wall Street Journal"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.009_bib10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jdcr.2020.04.011","article-title":"Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings","volume":"6","author":"Kolivras","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib11","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/jdv.16682","article-title":"A\u00a0clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection","volume":"34","author":"El Hachem","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib12","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2020.05.145","article-title":"Chilblain-like acral lesions during the COVID-19 pandemic (\u201cCOVID toes\u201d): histologic, immunofluorescence and immunohistochemical study of 17 cases","volume":"83","author":"Kanitakis","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.009_bib13","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1111\/jdv.16644","article-title":"Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic","volume":"34","author":"Garc\u00eda-Gil","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.1981.01650010032019","article-title":"A\u00a0distinctive variant of pernio: clinical and histopathologic study of nine cases","volume":"117","author":"Herman","year":"1981","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/DAD.0b013e3181af1d24","article-title":"Perniosis: clinical and histopathological analysis","volume":"32","author":"Boada","year":"2010","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/art.40375","article-title":"Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"70","author":"Sunderk\u00f6tter","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.mayocp.2021.01.009_bib17","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1111\/jdv.16689","article-title":"Retiform purpura as a dermatological sign of coronavirus disease 2019 (COVID-19) coagulopathy","volume":"34","author":"Bosch-Amate","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib18","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1111\/jdv.16687","article-title":"Acro-ischaemia and COVID-19 infection: clinical and histopathological features","volume":"34","author":"Calv\u00e3o","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib19","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1111\/jdv.16763","article-title":"Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy","volume":"34","author":"Del Giudice","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjd.19415","article-title":"The differing pathophysiologies that underlie COVID-19 associated perniosis and thrombotic retiform purpura: a case series","volume":"184","author":"Magro","year":"2020","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jamadermatol.2018.5077","article-title":"Assessment of clinical response to janus kinase inhibition in patients with familial chilblain lupus and TREX1 mutation","volume":"155","author":"Zimmermann","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000437224","article-title":"Vasospasm is a consistent finding in pernio (chilblains) and a possible clue to pathogenesis","volume":"231","author":"Shahi","year":"2015","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/MAJ.0000000000000284","article-title":"Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms","volume":"348","author":"Jones Buie","year":"2014","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1525-1470.2000.01722.x","article-title":"Childhood pernio and cryoproteins","volume":"17","author":"Weston","year":"2000","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10875-018-0584-x","article-title":"TREX-1-related disease associated with the presence of cryofibrinogenemia","volume":"39","author":"Paradis","year":"2019","journal-title":"J\u00a0Clin Immunol"},{"issue":"12","key":"10.1016\/j.mayocp.2021.01.009_bib26","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/ijd.15234","article-title":"High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak","volume":"59","author":"G\u00f3mez-Fern\u00e1ndez","year":"2020","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2020.05.109","article-title":"American Academy of Dermatology Ad Hoc Task Force on COVID-19. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.009_bib28","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","article-title":"The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaad.2020.09.007","article-title":"Timing of PCR and antibody testing in patients with COVID-19-associated dermatologic manifestations","volume":"84","author":"Freeman","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/pde.14215","article-title":"Chilblains in children in the setting of COVID-19 pandemic","volume":"37","author":"Andina","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/pde.14210","article-title":"Chilblain-like lesions in children following suspected COVID-19 infection","volume":"37","author":"Colonna","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.009_bib32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/pde.14269","article-title":"Chilblains in children in the time of COVID-19: new evidence with serology assay","volume":"37","author":"Colonna","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.009_bib33","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1111\/jdv.16665","article-title":"Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review","volume":"34","author":"Docampo-Sim\u00f3n","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib34","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1111\/jdv.16751","article-title":"Major cluster of paediatric \u2018true\u2019 primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown","volume":"34","author":"Neri","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.mayocp.2021.01.009_bib35","author":"Hubiche"},{"key":"10.1016\/j.mayocp.2021.01.009_bib36","doi-asserted-by":"crossref","first-page":"109959","DOI":"10.1016\/j.mehy.2020.109959","article-title":"A\u00a0chilblain epidemic during the COVID-19 pandemic: a sign of natural resistance to SARS-CoV-2?","volume":"144","author":"Lipsker","year":"2020","journal-title":"Med Hypotheses"},{"issue":"10","key":"10.1016\/j.mayocp.2021.01.009_bib37","doi-asserted-by":"crossref","first-page":"e546","DOI":"10.1111\/jdv.16688","article-title":"No antibody response in acral cutaneous manifestations associated with COVID-19?","volume":"34","author":"Mahieu","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"10247","key":"10.1016\/j.mayocp.2021.01.009_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study","volume":"396","author":"Stringhini","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.009_bib39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.mayocp.2021.01.009_bib40","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib41","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMc2025179","article-title":"Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild Covid-19","volume":"383","author":"Ibarrondo","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"47","key":"10.1016\/j.mayocp.2021.01.009_bib42","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.15585\/mmwr.mm6947a2","article-title":"Decline in SARS-CoV-2 antibodies after mild infection among frontline health care personnel in a multistate hospital network\u201412 states, April-August 2020","volume":"69","author":"Self","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"10.1016\/j.mayocp.2021.01.009_bib43","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"7821","key":"10.1016\/j.mayocp.2021.01.009_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"issue":"7833","key":"10.1016\/j.mayocp.2021.01.009_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19","volume":"587","author":"Braun","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3201\/eid2701.203611","article-title":"Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France","volume":"27","author":"Gallais","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib47","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/eji.201545765","article-title":"Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN-I responses","volume":"46","author":"Honke","year":"2016","journal-title":"Eur J Immunol"},{"issue":"6522","key":"10.1016\/j.mayocp.2021.01.009_bib48","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.abe1107","article-title":"Preexisting and de novo humoral immunity to SARS-CoV-2 in humans","volume":"370","author":"Ng","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib49","doi-asserted-by":"crossref","first-page":"e143380","DOI":"10.1172\/JCI143380","article-title":"Recent endemic coronavirus infection is associated with less severe COVID-19","volume":"131","author":"Sagar","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"10","key":"10.1016\/j.mayocp.2021.01.009_bib50","doi-asserted-by":"crossref","first-page":"e572","DOI":"10.1111\/jdv.16733","article-title":"Histological findings in chilblain-lupus like COVID lesions: in search of an answer to understand their aetiology","volume":"34","author":"Rodr\u00edguez-Villa Lario","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.009_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/DAD.0000000000000945","article-title":"Comparative analysis of chilblain lupus erythematosus and idiopathic perniosis: histopathologic features and immunohistochemistry for CD123 and CD30","volume":"40","author":"Wang","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.009_bib52","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaad.2020.06.1018","article-title":"New insights in COVID-19-associated chilblains: a comparative study with chilblain lupus erythematosus","volume":"83","author":"Battesti","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/dermatopathology7030010","article-title":"Type I interferon signature in chilblain-like lesions associated with the COVID-19 pandemic","volume":"7","author":"Aschoff","year":"2020","journal-title":"Dermatopathology (Basel)"},{"key":"10.1016\/j.mayocp.2021.01.009_bib54","author":"Hubiche"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/pde.14246","article-title":"Erythema multiforme-like lesions in children and COVID-19","volume":"37","author":"Torrelo","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.009_bib56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultraestructural study of seven paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.009_bib57","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/bjd.19338","article-title":"COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient","volume":"183","author":"Santonja","year":"2020","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib58","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/cup.13830","article-title":"Perniosis during the COVID-19 pandemic: negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2","volume":"47","author":"Ko","year":"2020","journal-title":"J\u00a0Cutan Pathol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/cup.13866","article-title":"Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein","volume":"48","author":"Ko","year":"2020","journal-title":"J\u00a0Cutan Pathol"},{"issue":"15","key":"10.1016\/j.mayocp.2021.01.009_bib60","doi-asserted-by":"crossref","first-page":"adv00249","DOI":"10.2340\/00015555-3612","article-title":"Similarities in cutaneous histopathological patterns between COVID-19-positive and COVID-19 high-risk patients with skin dermatosis","volume":"100","author":"Gianotti","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.009_bib61","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jamadermatol.2020.2368","article-title":"Evaluation of chilblains as a manifestation of the COVID-19 pandemic","volume":"156","author":"Herman","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.mayocp.2021.01.009_bib62","author":"Gambichler"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.009_bib63","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.clindermatol.2020.06.005","article-title":"Paraviral eruptions in the era of COVID-19: do some skin manifestations point to a natural resistance to SARS-CoV-2?","volume":"38","author":"Lipsker","year":"2020","journal-title":"Clin Dermatol"},{"issue":"6965","key":"10.1016\/j.mayocp.2021.01.009_bib64","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.009_bib66","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1128\/JVI.02232-10","article-title":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response","volume":"85","author":"Glowacka","year":"2011","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.mayocp.2021.01.009_bib67","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","volume":"76","author":"Verdecchia","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/CIRCRESAHA.116.310509","article-title":"Clinical relevance and role of neuronal AT1 receptors in ADAM17-mediated ACE2 shedding in neurogenic hypertension","volume":"121","author":"Xu","year":"2017","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib69","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","volume":"88","author":"Heurich","year":"2014","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib70","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect Dis Poverty"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib71","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J\u00a0Pathol"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.009_bib72","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jaad.2020.08.057","article-title":"Skin is a potential host of SARS-CoV-2: a clinical, single-cell transcriptome-profiling and histologic study","volume":"83","author":"Sun","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","article-title":"Impact of sex and gender on COVID-19 outcomes in Europe","volume":"11","author":"Gebhard","year":"2020","journal-title":"Biol Sex Differ"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib74","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","article-title":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission","volume":"11","author":"Peckham","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.mayocp.2021.01.009_bib75","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19)\u2014United States, February 12-March 16, 2020","volume":"69","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib76","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11906-012-0319-y","article-title":"The \u201chis and hers\u201d of the renin-angiotensin system","volume":"15","author":"Hilliard","year":"2013","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib77","doi-asserted-by":"crossref","first-page":"H516","DOI":"10.1152\/ajpheart.00509.2018","article-title":"Age-related differences in the cutaneous vascular response to exogenous angiotensin II","volume":"316","author":"Lang","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.mayocp.2021.01.009_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2015.11.004","article-title":"Estradiol, acting through ER\u03b1, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1-7 production","volume":"422","author":"Mompe\u00f3n","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib79","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/CIRCRESAHA.116.306531","article-title":"Thirty years of saying NO: sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator","volume":"119","author":"Vanhoutte","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib80","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaad.2020.04.032","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated","volume":"83","author":"Wambier","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.009_bib81","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/cmi.2014.101","article-title":"Estrogen upregulates MICA\/B expression in human non-small cell lung cancer through the regulation of ADAM17","volume":"12","author":"Ren","year":"2015","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib82","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/2159-8290.CD-13-1010","article-title":"The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis","volume":"4","author":"Lucas","year":"2014","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib83","doi-asserted-by":"crossref","first-page":"e140766","DOI":"10.1172\/JCI140766","article-title":"Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium","volume":"131","author":"Schuler","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib84","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bbrc.2020.01.008","article-title":"Estrogen downregulates gp130 expression in HUVECs by regulating ADAM10 and ADAM17 via the estrogen receptor","volume":"523","author":"Zhou","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib85","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/cancers11111736","article-title":"ADAM17 activity and IL-6 trans-signaling in inflammation and cancer","volume":"11","author":"Schumacher","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib86","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/eji.201646725","article-title":"Human pDCs display sex-specific differences in type I interferon subtypes and interferon \u03b1\/\u03b2 receptor expression","volume":"47","author":"Ziegler","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mayocp.2021.01.009_bib87","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.3389\/fimmu.2018.03167","article-title":"Sex and pubertal differences in the type 1 interferon pathway associate with both X chromosome number and serum sex hormone concentration","volume":"9","author":"Webb","year":"2018","journal-title":"Front Immunol"},{"issue":"19","key":"10.1016\/j.mayocp.2021.01.009_bib88","doi-asserted-by":"crossref","first-page":"eaap8855","DOI":"10.1126\/sciimmunol.aap8855","article-title":"TLR7 escapes X chromosome inactivation in immune cells","volume":"3","author":"Souyris","year":"2018","journal-title":"Sci Immunol"},{"issue":"7837","key":"10.1016\/j.mayocp.2021.01.009_bib89","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mayocp.2021.01.009_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"issue":"6515","key":"10.1016\/j.mayocp.2021.01.009_bib91","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.mayocp.2021.01.009_bib92","author":"Pairo-Castineira"},{"issue":"6515","key":"10.1016\/j.mayocp.2021.01.009_bib93","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.009_bib94","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000350536","article-title":"Mechanisms and implications of age-associated impaired innate interferon secretion by dendritic cells: a mini-review","volume":"59","author":"Agrawal","year":"2013","journal-title":"Gerontology"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib95","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11357-011-9244-2","article-title":"Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women","volume":"34","author":"Kim","year":"2012","journal-title":"Age (Dordr)"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib96","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/jc.2005-1097","article-title":"Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men","volume":"91","author":"Maggio","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.mayocp.2021.01.009_bib97","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jmv.25770","article-title":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19","volume":"92","author":"Gao","year":"2020","journal-title":"J\u00a0Med Virol"},{"issue":"564","key":"10.1016\/j.mayocp.2021.01.009_bib98","doi-asserted-by":"crossref","first-page":"eabd5487","DOI":"10.1126\/scitranslmed.abd5487","article-title":"Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients","volume":"12","author":"Pierce","year":"2020","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib99","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41590-020-00826-9","article-title":"Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum","volume":"22","author":"Weisberg","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.mayocp.2021.01.009_bib100","author":"Zimmermann"},{"issue":"7","key":"10.1016\/j.mayocp.2021.01.009_bib101","doi-asserted-by":"crossref","first-page":"102567","DOI":"10.1016\/j.autrev.2020.102567","article-title":"Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions","volume":"19","author":"Jamilloux","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.immuni.2018.12.027","article-title":"Plasmacytoid dendritic cells: development, regulation, and function","volume":"50","author":"Reizis","year":"2019","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.009_bib103","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.chom.2019.03.005","article-title":"Plasmacytoid dendritic cells and infected cells form an interferogenic synapse required for antiviral responses","volume":"25","author":"Assil","year":"2019","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.009_bib104","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1084\/jem.20181359","article-title":"A\u00a0pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection","volume":"216","author":"Barrat","year":"2019","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"10.1016\/j.mayocp.2021.01.009_bib105","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1073\/pnas.1117359109","article-title":"Plasmacytoid dendritic cells control T-cell response to chronic viral infection","volume":"109","author":"Cervantes-Barragan","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib106","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset\u00a0alteration in COVID-19 pneumonia","volume":"221","author":"Wang","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.mayocp.2021.01.009_bib107","doi-asserted-by":"crossref","first-page":"102763","DOI":"10.1016\/j.ebiom.2020.102763","article-title":"Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients","volume":"55","author":"Liu","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib108","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1080\/22221751.2020.1780953","article-title":"SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists","volume":"9","author":"Yuen","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"6504","key":"10.1016\/j.mayocp.2021.01.009_bib109","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.009_bib110","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib111","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJMc2013656","article-title":"Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19","volume":"383","author":"Bowles","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.mayocp.2021.01.009_bib112","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/jth.14867","article-title":"Lupus anticoagulant is frequent in patients with Covid-19","volume":"18","author":"Harzallah","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib113","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","article-title":"Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients","volume":"50","author":"Zhang","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"570","key":"10.1016\/j.mayocp.2021.01.009_bib114","doi-asserted-by":"crossref","first-page":"eabd3876","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.mayocp.2021.01.009_bib115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11926-018-0773-x","article-title":"Role of infectious diseases in the antiphospholipid syndrome (including its catastrophic variant)","volume":"20","author":"Mendoza-Pinto","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib116","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2010.09829.x","article-title":"Chilblains and antiphospholipid antibodies: report of four cases and review of the literature","volume":"163","author":"Lutz","year":"2010","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.009_bib117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamadermatol.2020.2800","article-title":"Livedoid and purpuric skin eruptions associated with coagulopathy in severe COVID-19","volume":"156","author":"Droesch","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.009_bib118","first-page":"1651","article-title":"COVID-19 related coagulopathy: a distinct entity?","volume":"9","author":"Marchandot","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"6","key":"10.1016\/j.mayocp.2021.01.009_bib119","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mayocp.2021.01.009_bib120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.009_bib121","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/micc.12120","article-title":"Roles of coagulation and fibrinolysis in angiotensin II-enhanced microvascular thrombosis","volume":"21","author":"Senchenkova","year":"2014","journal-title":"Microcirculation"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.009_bib122","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/HYPERTENSIONAHA.111.173856","article-title":"Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis","volume":"58","author":"Senchenkova","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib123","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/cei.12467","article-title":"Angiotensin II in inflammation, immunity and rheumatoid arthritis","volume":"179","author":"Chang","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.009_bib124","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/HYPERTENSIONAHA.118.12286","article-title":"Novel role of T cells and IL-6 (interleukin-6) in angiotensin II-induced microvascular dysfunction","volume":"73","author":"Senchenkova","year":"2019","journal-title":"Hypertension"},{"issue":"12","key":"10.1016\/j.mayocp.2021.01.009_bib125","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci"},{"issue":"20","key":"10.1016\/j.mayocp.2021.01.009_bib126","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.3390\/ijms20205214","article-title":"Endothelial dysfunction in primary aldosteronism","volume":"20","author":"Chen","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib127","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.0802886","article-title":"Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity","volume":"184","author":"Herrada","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.009_bib128","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1159\/000479272","article-title":"Angiotensin II regulates dendritic cells through activation of NF-kappaB \/p65, ERK1\/2 and STAT1 pathways","volume":"42","author":"Meng","year":"2017","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"10.1016\/j.mayocp.2021.01.009_bib129","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4081\/cp.2020.1271","article-title":"COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review","volume":"10","author":"Cavezzi","year":"2020","journal-title":"Clin Pract"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.009_bib130","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of TH17\/Treg balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mayocp.2021.01.009_bib131","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-020-00263-3","article-title":"Hypoxia: a key feature of COVID-19 launching activation of HIF-1 and cytokine storm","volume":"17","author":"Jahani","year":"2020","journal-title":"J\u00a0Inflamm (Lond)"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib132","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.0906-6705.2004.0139.x","article-title":"Human skin: source of and target organ for angiotensin II","volume":"13","author":"Steckelings","year":"2004","journal-title":"Exp. Dermatol"},{"issue":"10","key":"10.1016\/j.mayocp.2021.01.009_bib133","doi-asserted-by":"crossref","first-page":"H1215","DOI":"10.1152\/ajpheart.00017.2015","article-title":"Angiotensin II type I receptor blockade attenuates reflex cutaneous vasoconstriction in aged but not young skin","volume":"308","author":"Lang","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.mayocp.2021.01.009_bib134","doi-asserted-by":"crossref","first-page":"H1496","DOI":"10.1152\/ajpheart.2001.280.4.H1496","article-title":"Nonnoradrenergic mechanism of reflex cutaneous vasoconstriction in men","volume":"280","author":"Stephens","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"10.1016\/j.mayocp.2021.01.009_bib135","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1113\/JP270062","article-title":"Impaired increases in skin sympathetic nerve activity contribute to age-related decrements in reflex cutaneous vasoconstriction","volume":"593","author":"Greaney","year":"2015","journal-title":"J\u00a0Physiol"},{"issue":"3","key":"10.1016\/j.mayocp.2021.01.009_bib136","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol Rev"},{"issue":"11","key":"10.1016\/j.mayocp.2021.01.009_bib137","doi-asserted-by":"crossref","first-page":"e684","DOI":"10.1111\/jdv.16773","article-title":"Relapsing symmetric livedo reticularis in a patient with COVID-19 infection","volume":"34","author":"Verheyden","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.mayocp.2021.01.009_bib138","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/07853890.2020.1763449","article-title":"Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic","volume":"52","author":"Pulia","year":"2020","journal-title":"Ann Med"},{"key":"10.1016\/j.mayocp.2021.01.009_bib139","doi-asserted-by":"crossref","first-page":"104114","DOI":"10.1016\/j.cellimm.2020.104114","article-title":"Protective immunity after COVID-19 has been questioned: what can we do without SARS-CoV-2-IgG detection?","volume":"353","author":"Melga\u00e7o","year":"2020","journal-title":"Cell Immunol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962100046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962100046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:35:18Z","timestamp":1758418518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561962100046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":137,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S002561962100046X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.01.009","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2021.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}